Journal
NEUROLOGICAL SCIENCES
Volume 28, Issue -, Pages S166-S178Publisher
SPRINGER-VERLAG ITALIA SRL
DOI: 10.1007/s10072-007-0772-6
Keywords
migraine; cluster headache; acute and preventive treatment; emerging drugs
Categories
Ask authors/readers for more resources
Migraine is a chronic neurological disease with heterogeneous characteristics resulting in a range of symptom profiles, burden and disability. It affects nearly 12% of the adult population in Western countries and up to 22% of the Brazilian population, imposing considerable suffering as well as personal, economic and social losses. The pharmacological treatment of migraine is divided into preventive and acute treatment. A better comprehension of migraine pathophysiology, as well as the finding of novel molecular targets, has led to a growing number of upcoming therapeutic opportunities. The same is true of cluster headache, which affects only about 0.07%-0.4% of most populations. This review focuses on current and emerging agents and procedures for the treatment of migraine and cluster headache.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available